|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▼
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
DASIGLUCAGON |
H04AA02 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/006214 |
24-07-2024 |
VALID
|
|
DELGOCITINIB |
D11AH11 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/006109 |
19-09-2024 |
VALID
|
|
DOPAMINE HYDROCHLORIDE |
C01CA04 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/006044 |
27-05-2024 |
VALID
|
|
EFANESOCTOCOG ALFA |
B02BD02 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/005968 |
17-06-2024 |
VALID
|
|
ELAFIBRANOR |
A05AX06 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/006231 |
19-09-2024 |
VALID
|
|
ERDAFITINIB |
L01EN01 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/006050 |
22-08-2024 |
VALID
|
|
FIDANACOGENE ELAPARVOVEC |
B02BD17 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/004774 |
24-07-2024 |
VALID
|
|
FLORTAUCIPIR (18F) |
V09AX07 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/006064 |
22-08-2024 |
VALID
|
|
FRUQUINTINIB |
L01EK04 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/005979 |
20-06-2024 |
VALID
|
|
INFLUENZA VACCINE (LIVE ATTENUATED, NASAL) |
J07BB03 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/006514 |
03-06-2024 |
VALID
|
|
INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED, PREPARED IN CELL CULTURES) |
J07BB02 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/006051 |
19-04-2024 |
VALID
|
|
INSULIN ICODEC |
A10AE07 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/005978 |
17-05-2024 |
VALID
|
|
IPTACOPAN |
L04AJ08 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/005764 |
17-05-2024 |
VALID
|
|
RETIFANLIMAB |
L01FF10 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/006194 |
19-04-2024 |
VALID
|
|
SINGLE-STRANDED 5' CAPPED MRNA ENCODING RESPIRATORY SYNCYTIAL VIRUS GLYCOPROTEIN F STABILIZED |
J07BX05 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/006278 |
22-08-2024 |
VALID
|
|
SOTATERCEPT |
C02KC06 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/005647 |
22-08-2024 |
VALID
|
|
SPARSENTAN |
C09XX01 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/005783 |
19-04-2024 |
VALID
|
|
TOFERSEN |
N07XX22 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/005493 |
29-05-2024 |
VALID
|
|
TORIPALIMAB |
L01FF13 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/006120 |
19-09-2024 |
VALID
|
|
VIBEGRON |
G04BD15 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/005957 |
27-06-2024 |
VALID
|
|
ZOLBETUXIMAB |
L01FX31 |
IT
|
POM
|
01-08-2025 |
EMEA/H/C/005868 |
19-09-2024 |
VALID
|
|
BRIVARACETAM |
N03AX23 |
IT
|
II
|
23-07-2025 |
|
|
VALID
|
|
CANNABIDIOL |
N03AX24 |
IT
|
I
|
23-07-2025 |
|
|
VALID
|
|
CENOBAMATE |
N03AX25 |
IT
|
II
|
23-07-2025 |
|
|
VALID
|
|
GANAXOLONE |
N03AX27 |
IT
|
Not authorised
|
23-07-2025 |
|
|
VALID
|
|
LACOSAMIDE |
N03AX18 |
IT
|
II
|
23-07-2025 |
|
|
VALID
|
|
LEVETIRACETAM |
N03AX14 |
IT
|
II
|
23-07-2025 |
|
|
VALID
|
|
PERAMPANEL |
N03AX22 |
IT
|
II
|
23-07-2025 |
|
|
VALID
|
|
STIRIPENTOL |
N03AX17 |
IT
|
POM
|
23-07-2025 |
|
|
VALID
|
|
TOPIRAMATE |
N03AX11 |
IT
|
II
|
23-07-2025 |
|
|
VALID
|
|
VALPROMIDE |
N03AG02 |
IT
|
II
|
22-07-2025 |
|
|
VALID
|
|
VIGABATRIN |
N03AG04 |
IT
|
II
|
22-07-2025 |
|
|
VALID
|
|
CARBAMAZEPINE |
N03AF01 |
IT
|
II
|
21-07-2025 |
|
|
VALID
|
|
ESLICARBAZEPINE |
N03AF04 |
IT
|
II
|
21-07-2025 |
|
|
VALID
|
|
OXCARBAZEPINE |
N03AF02 |
IT
|
II
|
21-07-2025 |
|
|
VALID
|
|
RUFINAMIDE |
N03AF03 |
IT
|
II
|
21-07-2025 |
|
|
VALID
|
|
VALPROIC ACID |
N03AG01 |
IT
|
II
|
21-07-2025 |
|
|
VALID
|
|
PRIMIDONE |
N03AA03 |
IT
|
II
|
16-07-2025 |
|
|
VALID
|
|
GLUCAGON |
H04AA01 |
IT
|
II
|
10-01-2025 |
|
|
VALID
|
|
GLYCERYL TRINITRATE |
C01DA02 |
IT
|
II
|
10-01-2025 |
|
|
VALID
|
|
HUMAN MENOPAUSAL GONADOTROPHIN |
G03GA02 |
IT
|
II
|
10-01-2025 |
|
|
VALID
|
|
HYDROCORTISONE |
H02AB09 |
IT
|
II
|
10-01-2025 |
|
11-02-2002 |
VALID
|
|
PARICALCITOL |
H05BX02 |
IT
|
II
|
10-01-2025 |
|
18-12-2014 |
VALID
|
|
PODOPHYLLOTOXIN |
D06BB04 |
IT
|
II
|
10-01-2025 |
|
|
VALID
|
|
TERIPARATIDE |
H05AA02 |
IT
|
II
|
10-01-2025 |
|
|
VALID
|
|
DROTAVERINE |
A03AD02 |
IT
|
Not authorised
|
09-01-2025 |
|
|
VALID
|
|
ESTRIOL |
G03CA04 |
IT
|
II
|
20-12-2024 |
|
|
VALID
|
|
ROSUVASTATIN, AMLODIPINE AND PERINDOPRIL |
C10BX14 |
IT
|
Not authorised
|
16-12-2024 |
|
|
VALID
|
|
ATORVASTATIN, ACETYLSALICYLIC ACID AND RAMIPRIL |
C10BX06 |
IT
|
Not authorised
|
12-12-2024 |
|
|
VALID
|
|
BEMPEDOIC ACID AND EZETIMIBE |
C10BA10 |
IT
|
Not authorised
|
10-12-2024 |
EMEA/H/C/004959 |
27-03-2020 |
VALID
|